Search for: "Hospira"
Results 141 - 160
of 487
Sort by Relevance
|
Sort by Date
15 Mar 2016, 10:24 am
Hospira. [2] The statute also eliminating the ‘in this country’ limitation for on-sale prior art and limited the one-year grace period associated with the on sale bar. [read post]
10 Mar 2016, 6:01 am
Hospira, Inc. [read post]
9 Mar 2016, 9:30 pm
Yet, according to one agency representative, the Hospira alert was the first time a product was called out for cybersecurity issues. [read post]
9 Mar 2016, 12:43 pm
Hospira, Inc., 791 F.3d 1368, 1370 (Fed. [read post]
9 Mar 2016, 12:43 pm
Hospira, Inc., 791 F.3d 1368, 1370 (Fed. [read post]
8 Mar 2016, 3:56 am
Hospira en banc decision. [read post]
22 Feb 2016, 7:49 am
Challenges to mega-mergers like Pfizer/Hospira and others are more likely to receive national press coverage than smaller transactions. [read post]
28 Dec 2015, 9:59 pm
Hospira Inc. [read post]
23 Dec 2015, 7:24 pm
This argument broke down as follows:In light of Hospira v Genentech [2014] EWCA Civ 1094 and Regeneron, the patent must make it possible to make a reasonable prediction that the invention will work across the scope of the claim – it must be plausible or credible. [read post]
25 Nov 2015, 10:40 am
Given that Hospira, Inc. was the original cross-appellant on the issues to be addressed, Hospira’s en banc brief is due 45 days from the date of the order. [read post]
19 Nov 2015, 9:17 pm
Hospira, Inc. [read post]
18 Nov 2015, 2:41 pm
” Computer World, IDG News Service (Oct. 17, 2012) “Citing hacking risk, FDA says Hospira pump shouldn’t be used. [read post]
16 Nov 2015, 5:14 pm
Hospira titled:Correcting your Patent Based upon Later Advances in Science,LBE has a quibble with the title of the PatentlyO post AND, more importantly, with the decision. [read post]
13 Nov 2015, 1:40 pm
Hospira and requested briefing on the following questions: (a) Do the circumstances presented here constitute a commercial sale under the on-sale bar of 35 U.S.C. [read post]
13 Nov 2015, 11:35 am
Giventhat Hospira, Inc. was the original cross-appellant on theissues to be addressed, Hospira, Inc. [read post]
12 Nov 2015, 11:41 am
Hospira (Fed. [read post]
12 Nov 2015, 11:34 am
Hospira responded by challenging the validity ofthe asserted claims of each of those patents. [read post]
10 Sep 2015, 11:18 am
Hospira (Fed. [read post]
8 Sep 2015, 3:13 pm
(“Ivera”) sued Hospira, Inc. [read post]
10 Aug 2015, 7:16 am
” The AP reported that Hospira “stopped making Symbiq pumps in 2013,” but an unknown number of the pumps are still in use. [read post]
